(firstQuint)Irinotecan and Temozolomide for Ewing Sarcoma.

 After standard multimodal therapy, the prognosis of relapsed and metastatic Ewing Sarcoma is dismal and unchanged over the last decades.

Thus, the investigators explored the activity of irinotecan combined with temozolomide in patients with relapsed and metastatic Ewing Sarcoma after the failure of first-line chemotherapy with doxorubicin, vincristine, cyclophosphamide, ifosphamide and etoposide.

.

 Irinotecan and Temozolomide for Ewing Sarcoma@highlight

The investigators explored the activity of irinotecan combined with temozolomide in patients with relapsed and metastatic Ewing Sarcoma.

